Navigation Links
Genmab Announces 2007 First Half Year Results
Date:8/22/2007

TCL).

On June 18, Genmab announced further development plans for HuMax-CD20(R) (ofatumumab), including clinical expansion into the new disease indications of multiple sclerosis and diffuse large B-cell lymphoma (DLBCL).

Effective June 18, Genmab became a member of the OMXC20 index on the OMX Nordic Exchange Copenhagen.

Genmab and GlaxoSmithKline reported positive results from the Phase II study of HuMax-CD20 in rheumatoid arthritis (RA) on June 15. These positive results triggered the first milestone payment to Genmab in the companies' collaboration.

On June 14, we announced initiation of a Phase II study of HuMax-CD20 in combination with CHOP chemotherapy in previously untreated follicular non-Hodgkin's lymphoma (NHL) patients.

On June 3, Genmab presented positive pre-clinical data illustrating the broad potential of HuMax-EGFr(TM) for the treatment of cancer.

On May 21, Genmab announced positive data showing that HuMax-HepC(TM) prevented Hepatitis C infection in a pre-clinical study.

On April 12, Genmab initiated a Phase II study of HuMax-EGFr in combination with chemo-radiation to treat non small cell lung cancer.

Outlook

Genmab is maintaining its financial guidance for the year. We project a 2007 operating loss of DKK 385 to 435 million and a net loss in the range of DKK 260 to 310 million. The company's projected December 31, 2007 cash position is expected to be in the range of DKK 3.8 to 3.9 billion.

Conference Call

Genmab will hold a conference call to discuss the first quarter results

tomorrow, Wednesday, August 22, 2007, at

3.00 pm CEST

2.00 pm BST

9.00 am EDT

The conference call will be held in English.

The dial in numbers are as follows:

+1-800-475-3716 (in the US) and ask for the Genmab conference call

+1-719-457-2728 (outside the US) and ask for the Genmab conference call

A live webcast of the call and relevant slides will be avai
'/>"/>

SOURCE Genmab A/S
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... third edition of Infusion Nursing: An ... the Infusion Nurses Society (INS), includes Totect(®), the ... are a group of chemotherapy medications including daunorubicin, ... in the treatment of various types of cancer ... to the INS publication: "In September 2007, the ...
(Date:12/14/2009)... US-based thermoforming company, has completed the delivery of Brookfield Engineering’s ... to a plastic enclosure with a smaller footprint and more ... ... (PRWEB) December 14, 2009 -- ThermoFab, a US-based thermoforming company, ... – helping Brookfield move from sheet metal to a plastic ...
(Date:12/11/2009)... a new explanation for differences in the severity of mental ... gene, the more serious the handicap. The genetic defect is ... is the amount of copies of the GDI1 gene that ... American Journal of Human Genetics , and are the result ... VIB, a life sciences research institute in Flanders, Belgium at ...
(Date:12/11/2009)... Gwathmey, Inc., a pre-clinical contract research ... aureus, and cardiovascular disease announces a new CEO. ... Rosalie Dunn, Ph.D., has joined Gwathmey as Chief ... years of experience working with small businesses and ... Dr. Dunn managed multimillion dollar portfolios for the ...
Breaking Biology Technology:Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2Amount of gene surplus determines severity of mental retardation in males 2Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2
... to get the Space Shuttle Discovery launched into space real-time ... flight surgeons using GE Healthcare's advanced heart monitoring ... NASA to monitor and track the health of the astronauts ... information with experts located outside NASA's mission control center in ...
... When creative concepts collide unexpectedly, this sudden accident incubates a ... a weird strategy. That gives birth to an extreme name ... are combined -- shaken, not stirred -- and that's how ... we must first learn the secrets of the various branding ...
... Wisconsin's neighbors has reaffirmed its support for stem cell ... Wisconsin. , ,Illinois Gov. Rod Blagojevich last week announced ... to support stem cell research. The announcement makes Illinois ... cell research after New Jersey, California and Connecticut. ...
Other Biology Technology:Accidental naming 2Accidental naming 3Accidental naming 4Illinois stem cell funding could aid issue's visibility 2
(Date:12/14/2009)... in preventing some of the stresses of open surgery on ... and organ dysfunction. Laparoscopy is a type of surgery in ... , By adding another gas to the carbon dioxide used ... University Medical Center have found they can preserve more normal ... nitrite (ENO) helped to open blood vessels and keep blood ...
(Date:12/13/2009)... JOLLA, CADecember 10, 2009Researchers at The Scripps Research ... a single protein from an ancient family of ... the body. In addition to providing guidance for ... supplies a theoretical underpinning for the protein,s possible ... degeneration. , The research was published in the ...
(Date:12/11/2009)... how bacteria under stress collectively weigh and initiate different ... how humans make strategic decisions that affect their health, ... Their study, published this week in the early online ... Academy of Sciences , was accomplished when the scientists ... the complex interplay of genes and proteins that colonies ...
Breaking Biology News(10 mins):Gas improves blood flow and organ status during minimally invasive surgery 2Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5Masimo Receives FDA Clearance for Masimo Rainbow SET 28R 29 Acoustic Respiration Rate Monitoring 62331 1Masimo Receives FDA Clearance for Masimo Rainbow SET 28R 29 Acoustic Respiration Rate Monitoring 62331 2Masimo Receives FDA Clearance for Masimo Rainbow SET 28R 29 Acoustic Respiration Rate Monitoring 62331 3Masimo Receives FDA Clearance for Masimo Rainbow SET 28R 29 Acoustic Respiration Rate Monitoring 62331 4Masimo Receives FDA Clearance for Masimo Rainbow SET 28R 29 Acoustic Respiration Rate Monitoring 62331 5Masimo Receives FDA Clearance for Masimo Rainbow SET 28R 29 Acoustic Respiration Rate Monitoring 62331 6Pharmaceutical and Life Sciences Companies Face Rising Tax Rates Says PricewaterhouseCoopers 6617 1Pharmaceutical and Life Sciences Companies Face Rising Tax Rates Says PricewaterhouseCoopers 6617 2Pharmaceutical and Life Sciences Companies Face Rising Tax Rates Says PricewaterhouseCoopers 6617 3Pharmaceutical and Life Sciences Companies Face Rising Tax Rates Says PricewaterhouseCoopers 6617 4Pharmaceutical and Life Sciences Companies Face Rising Tax Rates Says PricewaterhouseCoopers 6617 5Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 6615 1Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 6615 2Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 6615 3Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 6615 4
... 8, 2008) A new partnership between the U.S. Environmental ... and the Gund Institute for Ecological Economics at the ... determine the costs and benefits of actions that alter ... such as clean air and water, erosion and flood ...
... a suitable carrier for an oral vaccine against Alzheimer,s ... Institute of Bioscience and Biotechnology (KRIBB) in Korea and ... Biological Science at Wonkwang University. Although their research (1), ... , is still in the early stages, it is ...
... WI, JULY 7, 2008 -- The use of on-the-go ... with which farmers can manage their crops. Recently released ... precise management is necessarily more efficient. They discovered that ... calculating how large of an application area is optimal ...
Other Biology News:US EPA, UVM's Gund Institute team up to develop new ways to understand ecosystem services 2Can tomatoes carry the cure for Alzheimer's? 2
Vitellogenin (Japanese medaka) Standard...
... of gene expression) technology allows ... profiles generated by SAGE are ... transcripts making it possible to ... Kit is designed to make ...
...
Human PDGF, CF...
Biology Products: